NVIV InVivo Therapeutics Holdings Corp. gains 23% Oct 9, 2017

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focus on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for acute SCI; and Bioengineered Neural Trails injection program for the treatment of chronic SCI. Its proprietary technologies incorporate intellectual property licensed under an exclusive, worldwide license from Boston Children's Hospital and the Massachusetts Institute of Technology, as well as intellectual property that has been developed internally in collaboration with its advisors and partners. The company was founded in 2005 and is based in Cambridge, Massachusetts. http://www.priceseries.com/trade/NVIV-InVivo-Therapeutics-Holdings-Corp-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2017091320171009.html